Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population
Author(s) -
Alastair J. Martin,
Karen E. Wain,
Matthew T. Oetjens,
Kasia Tolwinski,
Emily Palen,
Abby E. Hare-Harris,
Lukas Habegger,
Evan K. Maxwell,
Jeffrey G. Reid,
Lauren K. Walsh,
Scott M. Myers,
David H. Ledbetter
Publication year - 2020
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2020.2159
Subject(s) - copy number variation , identification (biology) , population , medicine , psychiatry , genetics , psychology , biology , genome , environmental health , gene , botany
Population screening for medically relevant genomic variants that cause diseases such as hereditary cancer and cardiovascular disorders is increasing to facilitate early disease detection or prevention. Neuropsychiatric disorders (NPDs) are common, complex disorders with clear genetic causes; yet, access to genetic diagnosis is limited. We explored whether inclusion of NPD in population-based genomic screening programs is warranted by assessing 3 key factors: prevalence, penetrance, and personal utility.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom